MedPath

"A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, and Their Fixed Combination in Mild to Moderate Acne Vulgaris Patients."

Not Applicable
Active, not recruiting
Conditions
Acne Vulgaris
Interventions
Dietary Supplement: Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule
Drug: Topical Adapalene, Benzoyl Peroxide Gel
Registration Number
NCT05855629
Lead Sponsor
Treatment and Diagnostic Center of Private Enterprise "Asklepiy"
Brief Summary

The study aims to conduct a comparative clinical evaluation of the effectiveness of a fixed topical combination of adapalene with benzoyl peroxide in the form of a gel, a fixed combination of Lactobacillus rhamnosus, D-chiro-inositol and inulin in the form of capsules and their combination in patients with acne vulgaris of mild and moderate severity and laboratory lipid analysis profile of sebum, lipid metabolism, and IGF-1 (insulin-like growth factor).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Patients with mild to moderate level of Acne Vulgaris
Exclusion Criteria
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Topical Adapalene,Benzoyl Peroxide Gel,Oral Lactobacillus Rhamnosus,D-chiro-inositol,Inulin CapsuleTopical Adapalene, Benzoyl Peroxide Gel-
Topical Adapalene, Benzoyl Peroxide GelTopical Adapalene, Benzoyl Peroxide Gel-
Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin CapsuleOral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule-
Topical Adapalene,Benzoyl Peroxide Gel,Oral Lactobacillus Rhamnosus,D-chiro-inositol,Inulin CapsuleOral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule-
Primary Outcome Measures
NameTimeMethod
GAGS (Global Acne Grading System)180 days

The primary end point of the study is the intensity of acne manifestations according to the GAGS scale

Secondary Outcome Measures
NameTimeMethod
IGA (Investigator Global Assessment)180 days

The secondary end point of the study is the intensity of acne manifestations according to the IGA scale

Trial Locations

Locations (1)

TDC PE "Asklepiy"

🇺🇦

Uzhhorod, Zakarpattia, Ukraine

© Copyright 2025. All Rights Reserved by MedPath